A lack of properly funded research into ME or chronic fatigue syndrome has allowed unproven treatment claims to thrive.
Rigor académico, oficio periodístico
Artículos sobre Myalgic encephalomyelitis
Mostrando todos artículos
These findings may provide insights into better ways of managing long COVID.
With the impact and cost of long COVID becoming ever more apparent, ongoing pandemic responses will need to be about protecting quality of life as much as saving lives.
A better understanding of CFS could lead to new treatments.
University’s reasons for not releasing trial data are groundless.
Principales colaboradores
-
Professor emeritus, UCL
-
Professor of Biological Psychiatry, King's College London
-
Clinical Trial Research Manager, King's College London
-
Senior Research Fellow, Auckland University of Technology
-
Associate Professor of Neuroscience and Genetics, Sheffield Hallam University
-
Immunology Research Scientist, ME/CFS Research, Quadram Institute
